Siderophore Biomarker Detection for UPEC Virulence
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic methods for urinary tract infections (UTIs) caused by uropathogenic Escherichia coli (UPEC) are inadequate, leading to false negative results and recurrent infections due to the inability to distinguish between strains with high or low virulence potential, and the challenge of managing antibiotic resistance, which increases healthcare costs and risks of systemic infections.
Innovation Solution
A method for detecting yersiniabactin-expressing bacteria by analyzing samples for cupric yersiniabactin or hydroxphenyl-thiazolinyl-thiazolinyl (HPTT) using specific antibodies or mass spectrometry, and determining antibiotic susceptibility based on combinations of siderophores such as yersiniabactin, salmochelin, and aerobactin.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If culture-based diagnostic methods are used for UTI detection, then the diagnostic process is simple and inexpensive, but false negative results occur during antibiotic therapy and bacteria are not detected when not actively shed
Solution Approach 1:
The patent uses siderophores as intermediary biomarkers to detect bacterial presence and activity. Instead of directly detecting bacteria, the method detects siderophores secreted by bacteria, which remain detectable even when bacteria are not actively shedding or are in quiescent states. This intermediary approach resolves the contradiction by maintaining high detection accuracy while using a relatively simple immunoassay or mass spectrometry method.
Solution Approach 2:
The patent replaces traditional culture-based mechanical detection methods with molecular detection methods (immunoassays or mass spectrometry). This substitution eliminates the limitation of culture methods that require actively shedding bacteria, allowing detection of bacterial presence and virulence potential through molecular biomarkers (siderophores) that persist even when bacteria are not culturable.
2Loss of information
If current diagnostic methods are used, then the diagnostic approach is straightforward, but the ability to distinguish between strains with high or low virulence potential is lost
Solution Approach 1:
The patent segments the detection process into multiple specific assays targeting different siderophores (yersiniabactin, aerobactin, salmochelin) and their intermediates. Each siderophore detection provides specific information about bacterial strain characteristics and virulence potential. This segmentation allows the method to recover and utilize virulence information that would be lost in a single general detection approach.
Solution Approach 2:
The patent changes the detection parameter from general bacterial presence (culture positivity) to specific virulence-related biomarkers (siderophore types and combinations). By detecting which specific siderophores are present and their relative abundances, the method infers virulence potential and strain characteristics, thereby recovering virulence information through parameter transformation.
3Object-affected harmful factors
If broad-spectrum antibiotics are used aggressively to prevent systemic infections, then the risk of systemic infection is reduced, but antibiotic resistance increases and healthcare costs rise
Solution Approach 1:
The patent implements a feedback-based diagnostic system that provides specific information about bacterial virulence potential and strain characteristics through siderophore detection. This feedback enables clinicians to make informed decisions about antibiotic selection and intensity, avoiding unnecessary aggressive broad-spectrum antibiotic use when virulence is low, thereby reducing the selection pressure that drives antibiotic resistance while still preventing systemic infections when virulence is high.
Solution Approach 2:
The patent changes the treatment decision parameter from binary (culture positive/negative) to gradient-based (siderophore type, combination, and abundance). This parameter transformation allows for risk-stratified treatment approaches, where the intensity and spectrum of antibiotic therapy are matched to the actual virulence potential indicated by the siderophore profile, optimizing the balance between preventing systemic infection and minimizing antibiotic resistance selection.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for accurate detection of pathogenic bacteria, reduces false negatives, and strategically informs antibiotic use to prevent recurrent infections and antibiotic resistance, thereby lowering healthcare costs and minimizing the risk of systemic infections.
Implementation Method 1
contacting the sample with an antibody specific for cupric yersiniabactin
Implementation Method 2
cupric yersiniabactin or a product thereof... catalyzing the dismutation of one or more superoxide radicals
Data Source
AI summary
The present invention encompasses methods and compositions for detecting pathogenic bacteria. Additionally, the present invention encompasses methods and compositions for catalyzing the dismutation of superoxide radicals. Further, the present invention encompasses methods for determining the antibiotic susceptibility of pathogenic bacteria.